Sandrin C. Bergheanu

1.3k total citations
22 papers, 761 citations indexed

About

Sandrin C. Bergheanu is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Sandrin C. Bergheanu has authored 22 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 12 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cancer Research. Recurrent topics in Sandrin C. Bergheanu's work include Coronary Interventions and Diagnostics (10 papers), Lipoproteins and Cardiovascular Health (8 papers) and Acute Myocardial Infarction Research (7 papers). Sandrin C. Bergheanu is often cited by papers focused on Coronary Interventions and Diagnostics (10 papers), Lipoproteins and Cardiovascular Health (8 papers) and Acute Myocardial Infarction Research (7 papers). Sandrin C. Bergheanu collaborates with scholars based in Netherlands, Egypt and United Kingdom. Sandrin C. Bergheanu's co-authors include J. Wouter Jukema, Mathijs C. Bodde, Martin J. Schalij, Ayman K.M. Hassan, Josepha W.M. Plevier, Theo Stijnen, Jaapjan D. Snoep, Anho Liem, Douwe E. Atsma and Arnoud van der Laarse and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and Journal of Hepatology.

In The Last Decade

Sandrin C. Bergheanu

22 papers receiving 741 citations

Peers

Sandrin C. Bergheanu
Petr Toušek Czechia
D Sacco United States
Bert D. Dikkeschei Netherlands
Sandrin C. Bergheanu
Citations per year, relative to Sandrin C. Bergheanu Sandrin C. Bergheanu (= 1×) peers Zhanquan Li

Countries citing papers authored by Sandrin C. Bergheanu

Since Specialization
Citations

This map shows the geographic impact of Sandrin C. Bergheanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrin C. Bergheanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrin C. Bergheanu more than expected).

Fields of papers citing papers by Sandrin C. Bergheanu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrin C. Bergheanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrin C. Bergheanu. The network helps show where Sandrin C. Bergheanu may publish in the future.

Co-authorship network of co-authors of Sandrin C. Bergheanu

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrin C. Bergheanu. A scholar is included among the top collaborators of Sandrin C. Bergheanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrin C. Bergheanu. Sandrin C. Bergheanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klaassen, Erica S., Sandrin C. Bergheanu, Axel Petzold, et al.. (2019). Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial. CNS Neuroscience & Therapeutics. 25(6). 697–703. 14 indexed citations
2.
Bodde, Mathijs C., Paul Welsh, Sandrin C. Bergheanu, et al.. (2018). A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High‐Sensitivity Cardiac Troponin‐I in Subjects With Stable Cardiovascular Disease. Clinical Pharmacology & Therapeutics. 104(2). 311–316. 5 indexed citations
3.
Boudes, Pol, et al.. (2018). Seladelpar’s mechanism of action as a potential treatment for primary biliary cholangitis and non-alcoholic steato-hepatitis. Journal of Hepatology. 68. S235–S236. 3 indexed citations
4.
Bergheanu, Sandrin C., Mathijs C. Bodde, & J. Wouter Jukema. (2017). Pathophysiology and treatment of atherosclerosis. Netherlands Heart Journal. 25(4). 231–242. 191 indexed citations
5.
Gaudet, Daniel, Samir Saheb, Éric Bruckert, et al.. (2016). A pilot study of MBX-8025 in the treatment of homozygous familial hypercholesterolemia (HoFH). Atherosclerosis. 252. e253–e253. 6 indexed citations
6.
Ahmed, Tarek, Sandrin C. Bergheanu, Theo Stijnen, et al.. (2011). Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review. EuroIntervention. 7(4). 505–516. 24 indexed citations
7.
Bergheanu, Sandrin C., Arnoud van der Laarse, Johanna G. van der Bom, et al.. (2011). Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarction.. SHILAP Revista de lepidopterología. 30(5). 245–52. 7 indexed citations
8.
Bergheanu, Sandrin C., Douwe Pons, Bas L. van der Hoeven, et al.. (2010). The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stents. Heart and Vessels. 26(3). 235–241. 2 indexed citations
9.
Karalis, Ioannis, Sandrin C. Bergheanu, Ron Wolterbeek, et al.. (2010). Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters. Current Medical Research and Opinion. 26(10). 2301–2313. 23 indexed citations
10.
Bergheanu, Sandrin C., Douwe Pons, Ioannis Karalis, et al.. (2010). Genetic determinants of adverse outcome (restenosis, malapposition and thrombosis) after stent implantation. Interventional Cardiology. 2(2). 147–157. 1 indexed citations
12.
Hassan, Ayman K.M., Sandrin C. Bergheanu, Hosam Hasan‐Ali, et al.. (2009). Usefulness of Peak Troponin-T to Predict Infarct Size and Long-Term Outcome in Patients With First Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention. The American Journal of Cardiology. 103(6). 779–784. 53 indexed citations
13.
Bergheanu, Sandrin C., Douwe Pons, J. Wouter Jukema, et al.. (2009). Myocardial Infarction Occurs with a Similar 24 h Pattern in the 4G/5G Versions of Plasminogen Activator Inhibitor-1. Chronobiology International. 26(4). 637–652. 4 indexed citations
15.
Hassan, Ayman K.M., Sandrin C. Bergheanu, Theo Stijnen, et al.. (2009). Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. European Heart Journal. 31(10). 1172–1180. 206 indexed citations
16.
Bergheanu, Sandrin C., Ayman K.M. Hassan, Jouke Dijkstra, et al.. (2009). Post-intervention IVUS is not predictive for very late in-stent thrombosis in drug-eluting stents. Acta Cardiologica. 64(5). 611–616. 4 indexed citations
17.
Jukema, J. Wouter & Sandrin C. Bergheanu. (2008). Statins: established indications and controversial subgroups. Heart. 94(12). 1656–1662. 3 indexed citations
18.
Hoeven, Bas L. van der, Su‐San Liem, Jouke Dijkstra, et al.. (2008). Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions. 1(2). 192–201. 65 indexed citations
19.
Bergheanu, Sandrin C., Theo Reijmers, Aeilko H. Zwinderman, et al.. (2008). Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins. Current Medical Research and Opinion. 24(9). 2477–2487. 62 indexed citations
20.
Bergheanu, Sandrin C., Arie van Tol, Geesje M. Dallinga‐Thie, et al.. (2007). Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol. Current Medical Research and Opinion. 23(9). 2235–2240. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026